Sort   by:  
 Page size 
UnknownEflornithine as Postimmunotherapy Maintenance in High-Risk Neuroblastoma: Externally Controlled, Propensity Score-Matched Survival Outcome Comparisons.
Not available
S-EPMC10730038 | biostudies-literature
UnknownGenomic and Transcriptomic Analysis of Relapsed and Refractory Childhood Solid Tumors Reveals a Diverse Molecular Landscape and Mechanisms of Immune Evasion.
Not available
S-EPMC10240575 | biostudies-literature
UnknownFeasibility of implementing molecular-guided therapy for the treatment of patients with relapsed or refractory neuroblastoma.
Not available
S-EPMC4472210 | biostudies-literature
UnknownA pilot study of genomic-guided induction therapy followed by immunotherapy with difluoromethylornithine maintenance for high-risk neuroblastoma.
Not available
S-EPMC9675391 | biostudies-literature
Sort   by:  
 Page size